Semin Reprod Med 2013; 31(01): 082-094
DOI: 10.1055/s-0032-1331802
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Dedifferentiation, Transdifferentiation, and Reprogramming: Future Directions in Regenerative Medicine

Autor*innen

  • Cristina Eguizabal

    1   Center for Regenerative Medicine in Barcelona
  • Nuria Montserrat

    1   Center for Regenerative Medicine in Barcelona
  • Anna Veiga

    1   Center for Regenerative Medicine in Barcelona
    2   Reproductive Medicine Service, Institut Universitari Dexeus, Barcelona, Spain
  • Juan Carlos Izpisua Belmonte

    1   Center for Regenerative Medicine in Barcelona
    3   Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, California
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
17. Januar 2013 (online)

Abstract

The main goal of regenerative medicine is to replace damaged tissue. To do this it is necessary to understand in detail the whole regeneration process including differentiated cells that can be converted into progenitor cells (dedifferentiation), cells that can switch into another cell type (transdifferentiation), and somatic cells that can be induced to become pluripotent cells (reprogramming). By studying the regenerative processes in both nonmammal and mammal models, natural or artificial processes could underscore the molecular and cellular mechanisms behind these phenomena and be used to create future regenerative strategies for humans.